Literature DB >> 27126692

Pulmonary haemodynamics during recovery from maximum incremental cycling exercise.

Rudolf K F Oliveira1, Aaron B Waxman2, Manyoo Agarwal2, Roza Badr Eslam3, David M Systrom4.   

Abstract

Assessment of cardiac function during exercise can be technically demanding, making the recovery period a potentially attractive diagnostic window. However, the validity of this approach for exercise pulmonary haemodynamics has not been validated.The present study, therefore, evaluated directly measured pulmonary haemodynamics during 2-min recovery after maximum invasive cardiopulmonary exercise testing in patients evaluated for unexplained exertional intolerance. Based on peak exercise criteria, patients with exercise pulmonary hypertension (ePH; n=36), exercise pulmonary venous hypertension (ePVH; n=28) and age-matched controls (n=31) were analysed.By 2-min recovery, 83% (n=30) of ePH patients had a mean pulmonary artery pressure (mPAP) <30 mmHg and 96% (n=27) of ePVH patients had a pulmonary arterial wedge pressure (PAWP) <20 mmHg. Sensitivity of pulmonary hypertension-related haemodynamic measurements during recovery for ePH and ePVH diagnosis was ≤25%. In ePVH, pulmonary vascular compliance (PVC) returned to its resting value by 1-min recovery, while in ePH, elevated pulmonary vascular resistance (PVR) and decreased PVC persisted throughout recovery.In conclusion, we observed that mPAP and PAWP decay quickly during recovery in ePH and ePVH, compromising the sensitivity of recovery haemodynamic measurements in diagnosing pulmonary hypertension. ePH and ePVH had different PVR and PVC recovery patterns, suggesting differences in the underlying pulmonary hypertension pathophysiology.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27126692     DOI: 10.1183/13993003.00023-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension.

Authors:  Jason L Sanders; Yuchi Han; Mariana F Urbina; David M Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2019-10-30       Impact factor: 3.017

2.  Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

Authors:  Michele Covella; Ethan J Rowin; Nicholas S Hill; Ioana R Preston; Alberto Milan; Alexander R Opotowsky; Barry J Maron; Martin S Maron; Bradley A Maron
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

3.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

4.  Open label study of ambrisentan in patients with exercise pulmonary hypertension.

Authors:  Sergio A Segrera; Laurie Lawler; Alexander R Opotowsky; David Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2017-05-12       Impact factor: 3.017

5.  Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility.

Authors:  William D Wallace; Mehdi Nouraie; Stephen Y Chan; Michael G Risbano
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

6.  Exercise capacity in COPD patients with exercise-induced pulmonary hypertension.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-31

7.  Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.

Authors:  Inderjit Singh; Farbod N Rahaghi; Robert Naeije; Rudolf K F Oliveira; Rebecca R Vanderpool; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2019 Jul-Sep       Impact factor: 3.017

8.  Vital capacity and valvular dysfunction could serve as non-invasive predictors to screen for exercise pulmonary hypertension in the elderly based on a new diagnostic score.

Authors:  Simon Wernhart; Jürgen Hedderich; Eberhard Weihe
Journal:  J Cardiovasc Thorac Res       Date:  2021-01-30

9.  Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure.

Authors:  Rudolf K F Oliveira; Mariana Faria-Urbina; Bradley A Maron; Mario Santos; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2017-06-08       Impact factor: 3.017

10.  Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program.

Authors:  W H Wilson Tang; Jennifer D Wilcox; Miriam S Jacob; Erika B Rosenzweig; Barry A Borlaug; Robert P Frantz; Paul M Hassoun; Anna R Hemnes; Nicholas S Hill; Evelyn M Horn; Harsimran S Singh; David M Systrom; Ryan J Tedford; Rebecca R Vanderpool; Aaron B Waxman; Lei Xiao; Jane A Leopold; Franz P Rischard
Journal:  Circ Heart Fail       Date:  2020-02-24       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.